Newfound Research LLC Illumina, Inc. Transaction History

Newfound Research LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$181.58 - $368.0 $37,405 - $75,808	-206 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$303.87 - $423.8 $29,171 - $40,684	-96 Reduced 31.79%	206 $72,000
Q4 2021 Jan 19, 2022	BUY	$347.28 - $421.83 $46,188 - $56,103	133 Added 78.7%	302 $115,000
Q3 2021 Oct 14, 2021	BUY	$405.61 - $524.84 $3,244 - $4,198	8 Added 4.97%	169 $69,000
Q2 2021 Jul 19, 2021	SELL	$372.84 - $481.5 $1,864 - $2,407	-5 Reduced 3.01%	161 $76,000
Q1 2021 Apr 28, 2021	SELL	$361.28 - $504.76 $63,946 - $89,342	-177 Reduced 51.6%	166 $64,000
Q4 2020 Jan 22, 2021	BUY	$292.7 - $370.96 $70,833 - $89,772	242 Added 239.6%	343 $127,000
Q3 2020 Oct 20, 2020	BUY	$268.51 - $400.74 $27,119 - $40,474	101 New	101 $31,000

900

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.2B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

Stay updated on Newfound Research LLC with notifications on news.